• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

MECAMYLAMINE Drug Record

  • Summary
  • Interactions
  • Claims
  • MECAMYLAMINE chembl:CHEMBL267936 Approved

    Alternate Names:

    MECAMYLAMINE

    Drug Info:

    Year of Approval 1956
    Drug Class antihypertensive agents
    Drug Indications for treatment of ADHD
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications motilitant
    (1 More Sources)

    Publications:

    Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol
    Shytle et al., 2002, Mecamylamine (Inversine): an old antihypertensive with new research directions., J Hum Hypertens
    Imming et al., 2006, Drugs, their targets and the nature and number of drug targets., Nat Rev Drug Discov
    Overington et al., 2006, How many drug targets are there?, Nat Rev Drug Discov
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Struthers et al., 2009, Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine., Pharmacol. Biochem. Behav.
    Eaton JB et al., 2003, Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells., Mol Pharmacol
  • MECAMYLAMINE   CHRNA2

    Interaction Score: 4.01

    Interaction Types & Directionality:
    antagonist (inhibitory)
    blocker (inhibitory)
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name AGI-004, mecamylamine transdermal patch, CR
    Novel drug target Established target
    Trial Name mecamylamine HCl , TC-5231

    PMIDs:
    12080428 17016423 17139284 11752352 19778551


    Sources:
    TdgClinicalTrial TEND

  • MECAMYLAMINE   CHRNA4

    Interaction Score: 0.54

    Interaction Types & Directionality:
    blocker (inhibitory)

    Interaction Info:

    PMIDs:
    14645658


    Sources:
    TTD

  • MECAMYLAMINE   CYP2C9

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • MECAMYLAMINE   CYP1A2

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • MECAMYLAMINE   CYP2D6

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • MECAMYLAMINE   CYP3A4

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • TEND: MECAMYLAMINE

    • Version: 01-August-2011

    Alternate Names:

    Drug Info:
    Drug Class antihypertensive agents
    Year of Approval 1956

    Publications:

  • TdgClinicalTrial: MECAMYLAMINE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications motilitant
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

  • DTC: MECAMYLAMINE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL1398031 ChEMBL Drug ID

    Drug Info:

    Publications:
    Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol

  • TTD: Mecamylamine

    • Version: 2020.06.01

    Alternate Names:
    D0V8HA TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL267936

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21